| 1 |
21250866 | Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice. | 2011 Jul |
2 |
| 2 |
21676168 | Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. | 2011 Sep |
1 |
| 3 |
20807652 | Vascular dermatan sulfate and heparin cofactor II. | 2010 |
2 |
| 4 |
18281504 | Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. | 2008 Apr 15 |
6 |
| 5 |
17194895 | Heparin cofactor II modulates the response to vascular injury. | 2007 Mar |
5 |
| 6 |
17878401 | Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice. | 2007 Dec 15 |
2 |
| 7 |
15315969 | Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice. | 2004 Dec 15 |
6 |
| 8 |
11805133 | Heparin cofactor II inhibits arterial thrombosis after endothelial injury. | 2002 Jan |
2 |
| 9 |
1805447 | Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells. | 1991 Nov 1 |
2 |
| 10 |
3258496 | In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors. | 1988 Apr |
1 |